Free Trial
OTCMKTS:PCHM

PharmChem (PCHM) Stock Price, News & Analysis

$3.91 +0.09 (+2.36%)
As of 02:27 PM Eastern

About PharmChem Stock (OTCMKTS:PCHM)

Key Stats

Today's Range
$3.82
$3.91
50-Day Range
$2.97
$3.93
52-Week Range
$2.85
$3.95
Volume
1,067 shs
Average Volume
1,738 shs
Market Capitalization
$18.18 million
P/E Ratio
12.22
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

PharmChem Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
9th Percentile Overall Score

PCHM MarketRank™: 

PharmChem scored higher than 9% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for PharmChem.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of PharmChem is 12.22, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.21.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of PharmChem is 12.22, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.17.

  • Read more about PharmChem's valuation and earnings.
  • Percentage of Shares Shorted

    0.00% of the float of PharmChem has been sold short.
  • Short Interest Ratio / Days to Cover

    PharmChem has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

  • Dividend Yield

    PharmChem does not currently pay a dividend.

  • Dividend Growth

    PharmChem does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.00% of the float of PharmChem has been sold short.
  • Short Interest Ratio / Days to Cover

    PharmChem has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

  • News Coverage This Week

    MarketBeat has tracked 2 news articles for PharmChem this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, PharmChem insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    17.40% of the stock of PharmChem is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about PharmChem's insider trading history.
Receive PCHM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PharmChem and its competitors with MarketBeat's FREE daily newsletter.

PCHM Stock News Headlines

PharmChem, Inc. (PCHM) - Yahoo Finance
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.
PharmChem considers strategic alternatives
See More Headlines

PCHM Stock Analysis - Frequently Asked Questions

PharmChem's stock was trading at $3.06 at the beginning of the year. Since then, PCHM stock has increased by 27.8% and is now trading at $3.91.
View the best growth stocks for 2025 here
.

PharmChem Inc. (OTCMKTS:PCHM) announced its earnings results on Friday, May, 9th. The company reported $0.06 earnings per share for the quarter. The company earned $1.58 million during the quarter.

Shares of PCHM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/09/2025
Today
7/02/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - OUTP/HM CRE
Sub-Industry
Healthcare
Current Symbol
OTCMKTS:PCHM
CIK
N/A
Employees
170
Year Founded
N/A

Profitability

Trailing P/E Ratio
12.22
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$1.38 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$6.09 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
3,839,000
Market Cap
$18.17 million
Optionable
Not Optionable
Beta
0.76
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (OTCMKTS:PCHM) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners